Boehringer Ingelheim Chemicals Inc.
Boehringer Ingelheim Chemicals Inc. in Petersburg, Virginia, produces active pharmaceutical ingredients and intermediates. The company has been a wholly-owned subsidiary of the Boehringer Ingelheim group of companies since 1991.
Profile
Production in Petersburg is carried out in FDA-inspected and DEA-approved cGMP facilities. Excellent equipment utilisation of a four-shift system, together with a flexible organisation, ensures an attractive production environment and a favourable response time. The site covers a total area of 800,000 m², of which only 20 percent has so far been developed. A major expansion project is underway which will lead to additional active ingredient manufacturing capacity by 2009.
Services
- large-scale custom manufacturing of APIs and intermediates
- process development and optimisation, supported by development laboratories and in process/analytical control departments
- full regulatory support
- conduction of stability programmes for bulk APIs
Production profile
Products are manufactured for the pharmaceutical industry and Boehringer Ingelheim´s captive use. In addition to our standard product programme, capacity is available for custom manufacturing of APIs and advanced intermediates.
Production programme
- guaifenesin
- methocarbamol
- guanine
- calcium polycarbophil
- brompheniramine maleate
- metoclopramide
- doxapram
- glycopyrrolate
- diacetone fructose
- nevirapine
- methadone
- acetylmethadol HCl
Applied reactions and special operations
- Most kinds of common chemical reactions
